{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:20:25Z","timestamp":1792718425301,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:p>\n                    Elevated plasma levels of the osteocyte-derived hormone fibroblast growth factor 23 (FGF23) have emerged as a powerful biomarker of cardiovascular disease and death in patients with CKD. Whether elevated urinary or plasma FGF23 levels are prospectively associated with AKI and death in critically ill patients is unknown. We therefore conducted a prospective cohort study of 350 critically ill patients admitted to intensive care units at an academic medical center to investigate whether higher urinary FGF23 levels associate with the composite end point of AKI or in-hospital mortality (AKI\/death). We measured urinary FGF23 levels within 24 hours of admission to the intensive care unit. In a subcohort (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    =131) we also measured plasma levels of FGF23, calcium, phosphate, parathyroid hormone, and vitamin D metabolites. Urinary and plasma FGF23 levels, but not other mineral metabolites, significantly associated with AKI\/death. In multivariate analyses, patients in the highest compared with the lowest quartile of urinary FGF23 had a 3.9 greater odds (95% confidence interval, 1.6 to 9.5) of AKI\/death. Higher urinary FGF23 levels also independently associated with greater hospital, 90-day, and 1-year mortality; longer length of stay; and several other important adverse outcomes. In conclusion, elevated FGF23 levels measured in the urine or plasma may be a promising novel biomarker of AKI, death, and other adverse outcomes in critically ill patients.\n                  <\/jats:p>","DOI":"10.1681\/asn.2016080836","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T20:30:43Z","timestamp":1482870643000},"page":"1877-1885","source":"Crossref","is-referenced-by-count":88,"title":["Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness"],"prefix":"10.1681","volume":"28","author":[{"given":"David E.","family":"Leaf","sequence":"first","affiliation":[{"name":"Division of Renal Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirolos A.","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Medical Center, Utrecht, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Christov","sequence":"additional","affiliation":[{"name":"Endocrine Unit and Pediatric Nephrology Unit, Massachusetts General Hospital, Boston, Massachusetts;"},{"name":"Department of Medicine, New York Medical College, Valhalla, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[{"name":"Endocrine Unit and Pediatric Nephrology Unit, Massachusetts General Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata S.","family":"Sabbisetti","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine and Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushrut S.","family":"Waikar","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,12,27]]},"reference":[{"key":"B1-20231016","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.","volume":"16","author":"Chertow","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B2-20231016","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1681\/ASN.2005091017","article-title":"Declining mortality in patients with acute renal failure, 1988 to 2002.","volume":"17","author":"Waikar","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B3-20231016","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MNH.0b013e3280dd8c35","article-title":"The incidence and prognostic significance of acute kidney injury.","volume":"16","author":"Waikar","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B4-20231016","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2215\/CJN.00550112","article-title":"FGF-23 levels in patients with AKI and risk of adverse outcomes.","volume":"7","author":"Leaf","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5-20231016","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.kint.2015.12.035","article-title":"Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.","volume":"89","author":"Leaf","year":"2016","journal-title":"Kidney Int"},{"key":"B6-20231016","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ki.2013.150","article-title":"Plasma FGF23 levels increase rapidly after acute kidney injury.","volume":"84","author":"Christov","year":"2013","journal-title":"Kidney Int"},{"key":"B7-20231016","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD.","volume":"126","author":"Rossaint","year":"2016","journal-title":"J Clin Invest"},{"key":"B8-20231016","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"key":"B9-20231016","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jbmr.1740","article-title":"Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes.","volume":"28","author":"Bacchetta","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B10-20231016","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"B11-20231016","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/cen.12172","article-title":"Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes.","volume":"79","author":"Leaf","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B12-20231016","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1553-2712.2011.01047.x","article-title":"Vitamin D insufficiency and sepsis severity in emergency department patients with suspected infection.","volume":"18","author":"Ginde","year":"2011","journal-title":"Acad Emerg Med"},{"key":"B13-20231016","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"B14-20231016","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"B15-20231016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000439144","article-title":"Choice of reference serum creatinine in defining acute kidney injury.","volume":"131","author":"Siew","year":"2015","journal-title":"Nephron"},{"key":"B16-20231016","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B17-20231016","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury.","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"B18-20231016","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jc.2013-2963","article-title":"Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: A prospective, case-cohort study.","volume":"99","author":"di Giuseppe","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B19-20231016","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).","volume":"60","author":"Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B20-20231016","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD.","volume":"25","author":"Scialla","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B21-20231016","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"B22-20231016","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00467-013-2547-z","article-title":"FGF23 and mineral metabolism in the early post-renal transplantation period.","volume":"28","author":"Wesseling-Perry","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B23-20231016","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/ki.2013.526","article-title":"Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.","volume":"85","author":"Spichtig","year":"2014","journal-title":"Kidney Int"},{"key":"B24-20231016","doi-asserted-by":"crossref","first-page":"e70775","DOI":"10.1371\/journal.pone.0070775","article-title":"Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor.","volume":"8","author":"Zanchi","year":"2013","journal-title":"PLoS One"},{"key":"B25-20231016","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00304849","article-title":"The renal metabolism of insulin.","volume":"27","author":"Rabkin","year":"1984","journal-title":"Diabetologia"},{"key":"B26-20231016","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1681\/ASN.2014121253","article-title":"Renal clearance of mineral metabolism biomarkers.","volume":"27","author":"van Ballegooijen","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B27-20231016","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.2015.231","article-title":"Key role of the kidney in the regulation of fibroblast growth factor 23.","volume":"88","author":"Mace","year":"2015","journal-title":"Kidney Int"},{"key":"B28-20231016","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"B29-20231016","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy.","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"B30-20231016","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"B31-20231016","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20041799","article-title":"Role of the vitamin D receptor in FGF23 action on phosphate metabolism.","volume":"390","author":"Inoue","year":"2005","journal-title":"Biochem J"},{"key":"B32-20231016","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jbmr.1740","article-title":"FGF23 inhibits extra-renal synthesis of 1,25-dihydroxyvitamin D in human monocytes.","volume":"28","author":"Bacchetta","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B33-20231016","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/qjmed\/hcs014","article-title":"Vitamin D deficiency is associated with poor outcomes and increased mortality in severely ill patients.","volume":"105","author":"Arnson","year":"2012","journal-title":"QJM"},{"key":"B34-20231016","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/CCM.0b013e318206ccdf","article-title":"Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill.","volume":"39","author":"Braun","year":"2011","journal-title":"Crit Care Med"},{"key":"B35-20231016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.amjsurg.2011.07.021","article-title":"Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients.","volume":"204","author":"Matthews","year":"2012","journal-title":"Am J Surg"},{"key":"B36-20231016","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI81928","article-title":"CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders.","volume":"126","author":"Bai","year":"2016","journal-title":"J Clin Invest"},{"key":"B37-20231016","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","article-title":"Coupling fibroblast growth factor 23 production and cleavage: Iron deficiency, rickets, and kidney disease.","volume":"23","author":"Wolf","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B38-20231016","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1373\/clinchem.2010.161174","article-title":"Quantification of 1\u03b1,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry.","volume":"57","author":"Strathmann","year":"2011","journal-title":"Clin Chem"},{"key":"B39-20231016","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference.","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"B40-20231016","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1164\/ajrccm.160.1.9807118","article-title":"Outcomes research in critical care: Results of the American Thoracic Society Critical Care Assembly Workshop on outcomes research. The Members of the Outcomes Research Workshop.","volume":"160","author":"Rubenfeld","year":"1999","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201706000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:13Z","timestamp":1786130773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201706000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,27]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2016080836","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,27]]}}}